Related Experiment Video
Updated: Jul 15, 2026
10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach
Y D Gao1, S H Olson, J M Balkovec
1Department of Molecular Systems, Merck Research Laboratories, Madrid, Spain. yingduo_gao@merck.com
Summary
Drug discovery can reduce pregnane X receptor (PXR) activation by modifying drug candidates. Introducing polar groups to activators lowers PXR activity and CYP3A4 induction, preventing drug interactions.
Area of Science:
- Pharmacology
- Drug Discovery
- Molecular Biology
Background:
- The pregnane X receptor (PXR) regulates CYP3A4 gene expression.
- PXR activation can lead to CYP3A4 overexpression, causing drug-drug interactions.
- Reducing PXR activation by drug candidates is crucial in drug discovery.
Purpose of the Study:
- To provide structural insights for attenuating PXR activation by drug candidates.
- To understand the structure-activity relationship of PXR activators.
- To design and synthesize novel compounds with reduced PXR activity.
Main Methods:
- Molecular docking to model PXR activator interactions.
- Structure-activity relationship analysis of PXR activators.
- Synthesis and in vitro testing of designed analogues.
Main Results:
- Docking models suggested that polar groups reduce hPXR activity by destabilizing hydrophobic interactions.
- Synthesized analogues with polar groups showed significantly lower hPXR activation.
- These analogues also demonstrated decreased CYP3A4 induction in human hepatocytes.
Conclusions:
- Introducing polar groups to PXR activators is a viable strategy to attenuate hPXR activation.
- This approach can reduce CYP3A4 induction and mitigate drug-drug interaction risks.
- Structural modifications, like destabilizing receptor helices, offer further avenues for controlling PXR activity.
Related Concept Videos
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...